Extramucosal pyriplasty without stenting for management of pyriform aperture stenosis
- 83 Downloads
The current management options of congenital pyriform aperture stenosis (CNPAS) are either conservative measures awaiting further growth of the bony nasal framework or surgical intervention that focuses on bone removal from the margin of the pyriform aperture (PA) without exposure of the nasolacrimal duct (NLD) followed by stenting. Recently, CT measurements of the nasal cavity in CNPAS have shed light that the site of maximal bony obstruction corresponds to the bony buttress encasing the NLD rather than the margin of the PA as initially thought. Herein, we present an extramucosal pyriplasty technique that can be used without stenting to enlarge the PA and achieve immediate and sustained relief of nasal obstruction.
Retrospective chart review of 4 patients with radiologically confirmed CNPAS who had undergone extramucosal pyriplasty without stenting during the period from 2012 to 2016.
Three patients were full term without any clinically detectable congenital anomaly. The fourth patient was preterm infant who needed ICU management. On computerized tomography scan, the PA width ranged from 5.8 to 7.1 mm with a mean of 6.4 mm while site of maximal stenosis ranged from 5.4 to 6.8 with a mean of 6 mm. Extramucosal pyriplasty relieved nasal obstruction and restored normal oral feeding in all patients. Postoperative follow-up endoscopy revealed an adequately patent airway with no scarring, granulation or restenosis.
Extramucosal pyriplasty with decompression of the NLD without stenting is a treatment modality for CNPAS that provides prompt sustainable relief of nasal obstruction and avoids the drawbacks of stenting and shortcomings of the current conservative methods.
KeywordsPyriform aperture Congenital Stenosis Neonatal Nasal Nasolacrimal duct Stenting
No funding grants.
Conflict of interest
All authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consents were obtained from all individual participants included in the study.
- 2.Belden CJ, Mancuso AA, Schmalfuss IM (1999) CT features of congenital nasal piriform aperture stenosis: initial experience. Radiology 213(2):495–501. https://doi.org/10.1148/radiology.213.2.r99oc38495 CrossRefPubMedGoogle Scholar
- 4.Douglas B (1952) The relief of vestibular nasal obstruction by partial resection of the nasal process of the superior maxilla. Plast Reconstr Surg 9(1):42–51Google Scholar
- 8.Muenke M, Gurrieri F, Bay C, Yi DH, Collins AL, Johnson VP, Hennekam RC, Schaefer GB, Weik L, Lubinsky MS et al (1994) Linkage of a human brain malformation, familial holoprosencephaly, to chromosome 7 and evidence for genetic heterogeneity. Proc Natl Acad Sci USA 91(17):8102–8106CrossRefPubMedPubMedCentralGoogle Scholar
- 10.Gonik NJ, Cheng J, Lesser M, Shikowitz MJ, Smith LP (2015) Patient selection in congenital pyriform aperture stenosis repair—14 year experience and systematic review of literature. Int J Pediatr Otorhinolaryngol 79(2):235–239. https://doi.org/10.1016/j.ijporl.2014.12.016 CrossRefPubMedGoogle Scholar
- 15.Gunther L, Sari-Rieger A, Jablonka K, Rustemeyer J (2014) Clinical course and implications of congenital nasal pyriform stenosis and solitary median maxillary central incisor in a newborn: a case report. J Med Case Rep 8:215. https://doi.org/10.1186/1752-1947-8-215 CrossRefPubMedPubMedCentralGoogle Scholar
- 17.Wormald R, Hinton-Bayre A, Bumbak P, Vijayasekaran S (2015) Congenital nasal pyriform aperture stenosis 5.7 mm or less is associated with surgical intervention: a pooled case series. Int J Pediatr Otorhinolaryngol 79(11):1802–1805. https://doi.org/10.1016/j.ijporl.2015.07.026 CrossRefPubMedGoogle Scholar